Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
BMC Neurology
|
November 5, 2014
SOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axis
Jing Zhang, Huawei Jiang, Jiaofang Shao, et al.
Omics : a Journal of Integrative Biology
|
August 24, 2010
ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers
Xuefeng Fang, Wei Yu, Lisha Li, et al.
Omics : a Journal of Integrative Biology
|
August 24, 2010
ChIP-seq and Functional Analysis of the SOX2 Gene in Colorectal Cancers
Xuefeng Fang, Wei Yu, Lisha Li, et al.
Proteomics
|
February 1, 2011
Landscape of the SOX2 protein-protein interactome
Xuefeng Fang, Jae-Geun Yoon, Lisha Li, et al.
Eclinicalmedicine
|
April 15, 2024
Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial
Zixiang Wu, Chuanqiang Wu, Jing Zhao, et al.
Journal of Cellular Physiology
|
January 31, 2019
Zyxin as a potential cancer prognostic marker promotes the proliferation and metastasis of colorectal cancer cells
Chenhan Zhong, Jiekai Yu, Dan Li, et al.
BMC Genomics
|
January 8, 2011
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis
Xuefeng Fang, Jae-Geun Yoon, Lisha Li, et al.
Plos One
|
August 12, 2009
Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor
Biaoyang Lin, Jun Wang, Xu Hong, et al.
BMC Cancer
|
July 18, 2023
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study
Xuefeng Fang, Chenhan Zhong, Shanshan Weng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 10, 2025
ROS-Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling
Chenyang Ye, Mi Mi, Saimeng Shi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
BMC Neurology
|
November 5, 2014
SOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axis
Jing Zhang, Huawei Jiang, Jiaofang Shao, et al.
Omics : a Journal of Integrative Biology
|
August 24, 2010
ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers
Xuefeng Fang, Wei Yu, Lisha Li, et al.
Omics : a Journal of Integrative Biology
|
August 24, 2010
ChIP-seq and Functional Analysis of the SOX2 Gene in Colorectal Cancers
Xuefeng Fang, Wei Yu, Lisha Li, et al.
Proteomics
|
February 1, 2011
Landscape of the SOX2 protein-protein interactome
Xuefeng Fang, Jae-Geun Yoon, Lisha Li, et al.
Eclinicalmedicine
|
April 15, 2024
Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial
Zixiang Wu, Chuanqiang Wu, Jing Zhao, et al.
Journal of Cellular Physiology
|
January 31, 2019
Zyxin as a potential cancer prognostic marker promotes the proliferation and metastasis of colorectal cancer cells
Chenhan Zhong, Jiekai Yu, Dan Li, et al.
BMC Genomics
|
January 8, 2011
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis
Xuefeng Fang, Jae-Geun Yoon, Lisha Li, et al.
Plos One
|
August 12, 2009
Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor
Biaoyang Lin, Jun Wang, Xu Hong, et al.
BMC Cancer
|
July 18, 2023
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study
Xuefeng Fang, Chenhan Zhong, Shanshan Weng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 10, 2025
ROS-Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling
Chenyang Ye, Mi Mi, Saimeng Shi, et al.
Page
of 5